Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Methodology
Signal backtests
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Berrios John Joseph — Structure Therapeutics Inc. insider: 2 transactions · InsiderLens

/ / Berrios John Joseph

Berrios John Joseph

Chief Commercial Officer at Structure Therapeutics Inc. · on record since Aug 7, 2026

Insider trading activity of Berrios John Joseph

Transactions on record: 2; since Aug 7, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 7, 2026

Figures computed from official regulatory filings — .

Companies where Berrios John Joseph has traded

Structure Therapeutics Inc.2 tx · Aug 7, 2026

Track record of Berrios John Joseph

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Berrios John Joseph

Co-insiders of Berrios John Joseph

Bach Mark AllenStructure Therapeutics Inc.
BIOTECHNOLOGY VALUE FUND II LPStructure Therapeutics Inc.
BIOTECHNOLOGY VALUE FUND L PStructure Therapeutics Inc.
Biotechnology Value Trading Fund OS LPStructure Therapeutics Inc.
BVF GP HOLDINGS LLCStructure Therapeutics Inc.
BVF I GP LLCStructure Therapeutics Inc.
BVF II GP LLCStructure Therapeutics Inc.
BVF INC/ILStructure Therapeutics Inc.
BVF PARTNERS L P/ILStructure Therapeutics Inc.
BVF Partners OS Ltd.Structure Therapeutics Inc.
Coll Crespo BlasStructure Therapeutics Inc.
DOBMEIER ERICStructure Therapeutics Inc.
Farid RamyStructure Therapeutics Inc.
FIL LtdStructure Therapeutics Inc.
FMR LLCStructure Therapeutics Inc.
Hall AshleyStructure Therapeutics Inc.
Jung Melita SunStructure Therapeutics Inc.
LAMPERT MARK NStructure Therapeutics Inc.
Lang MatthewStructure Therapeutics Inc.
Lin XichenStructure Therapeutics Inc.
LOVE TED WStructure Therapeutics Inc.
Ma YingliStructure Therapeutics Inc.
Russell Angus C.Structure Therapeutics Inc.
Stevens Raymond CStructure Therapeutics Inc.
TETLOW SHARONStructure Therapeutics Inc.
Waldstreicher JoanneStructure Therapeutics Inc.
WELCH DANIEL GStructure Therapeutics Inc.
Yoon JunStructure Therapeutics Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src	Details
Structure Therapeutics Inc.	Aug 7, 2026	Award	140,766	0.00 USD	—	SEC
Structure Therapeutics Inc.	Aug 7, 2026	AwardD (derivative)	174,612	0.00 USD	—	SEC